| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |